Doctors were charting on their laptops at their kids’ baseball games before UnityPoint Health started rethinking how AI fits into clinical work. Now, ambient scribing, chart summarization and real-time capacity …
Health
-
-
Biologic drugs are a mainstay for treating immune-mediated diseases, but they still have limitations. Attovia Therapeutics is developing next-generation biologics that could offer better safety and efficacy with the bonus …
-
Almost half of Americans do not wake up “feeling rested” on most days, according to a new report from the U.S. Centers for Disease Control and Prevention (CDC). This should …
-
Health
How Policymakers Can Improve Obesity Treatment and Affordability, Per American College of Physicians
In a new paper published on Monday, the American College of Physicians (ACP) called on policymakers to advance obesity treatment access and affordability, including expanding insurance coverage and improving access …
-
Roughly 90% of drugs that enter clinical trials never make it to market — a failure rate that costs the pharmaceutical industry billions of dollars every year. On Tuesday, an …
-
Long-stay skilled nursing facility (SNF) members represent one of the most clinically complex populations served through Medicaid long-term services and supports (LTSS) and remain a foundational component of many state …
-
Most of us know the feeling. We wake up and, before we even get out of bed, we check our phone, the weather, our sleep score, overnight news, our schedule …
-
Telehealth is often touted as a way to expand healthcare access, particularly in rural communities. However, a new study found that rural populations continue to use telehealth at lower rates …
-
HHS unveiled a plan to reintroduce a rebate program for 340B drug discounts last week. The department, through the Health Resources and Services Administration (HRSA), is seeking to replace upfront …
-
Supernus Pharmaceuticals and Indivior Pharmaceuticals, companies that built businesses in different areas of neuroscience, have reached a deal to combine into an entity with a broader portfolio of products and …